BioMed X, a leading innovation engine for pharma, announced the relocation of its global headquarters to LAB22 at Heidelberg Innovation Park (hip), toget...
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. announced a shared commitment with the Trump Administration to lower the cost...
Evonik is investing in a new GMP drug product manufacturing facility for lipid-based drug delivery in Vancouver, Canada. The facility will increase Evoni...
Quoin Pharmaceuticals Ltd. (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and...
OmicsBank, a clinical data infrastructure company connecting fragmented hospital data for drug development and healthcare AI, announced $2.25 million in ...
Vector Science and Therapeutics Corp. ("Vector" or the "Company") is pleased to announce that the Company has entered into an investo...
Orum Therapeutics(“Orum” or the “Company”), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), ...
Skye Bioscience, Inc., and Redx Pharma Limited (“Redx”), a U.K. based, privately-held clinical-stage biotechnology company focused on develop...
The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) announced the recipients of the 2026 Stephenson Global Scholar Grants. In partnership...
Merck has reported strong financial results for the second quarter of 2026, driven by sustained growth across its Life Science and Electronics businesses...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...
Curium™ announced it is advancing plans for a second cyclotron investment in Romania, reaffirming the company’s long-term commitment to expan...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...
Australian medtech investor Bioshore Ventures and US neurotechnology investor Jumpspace Ventures join Wellumio's oversubscribed pre-Series A round in the f...
© 2026 Biopharma Boardroom. All Rights Reserved.
